AI Could Improve Prostate Cancer Brachytherapy
Enhanced deep-learning models have the potential to streamline prostate cancer brachytherapy treatment planning, according to investigators.
All articles by John Schieszer, MA
Imaging Needed to Identify Bone Metastases in Advanced PCa
Bone imaging cannot be safely omitted in advanced prostate cancer cases because no PSA level combined with T stage and Gleason Grade Group can accurately rule in bone metastases, a new study found.
Novel Antiandrogens and Cognitive Function
The authors of a recent review say they believe only a fraction of the men on androgen receptor-directed therapies who experience cognitive impairment report it.
Prospective Study Characterizes PCa Risk Linked to BRCA1, BRCA2 Mutations
For decades, it has been known that the mutations in the tumor suppressor genes BRCA1 and BRCA2 are associated with high risks of breast and ovarian cancer, but a new prospective cohort study provides the strongest evidence to date that these mutations are associated with the development of prostate cancer (PCa). The BRCA2 mutation appears…
Sipuleucel-T Efficacy, Safety in mCRPC Evaluated in Real World Study
The median time from first infusion of sipuleucel-T to death from prostate cancer was 42.7 months.
Precision Medicine for Lupus
Ongoing studies are now looking at pharmacogenetics when comparing mycophenolate mofitil and cyclophosphamide for treating lupus nephritis.
AACE Issues Guidance for Glucose Monitoring in Diabetes
The new consensus statement reflects the advances made in glucose monitoring technology and offers guidance for clinicians.
Testosterone Nasal Gel Effective for Hypogonadism, Low Side Effects
Three doses of testosterone nasal gel may help normalize testosterone levels in men with hypogonadism.
Next post in Hypogonadism
